Prevencio
Kirkland
About Prevencio
Prevencio is a developer of multi-proteomic biomarkers designed to revolutionize blood tests for cardiovascular disease. The company's biomarkers employ artificial intelligence to interrogate well-characterized clinical data sets to produce novel, multi-protein, algorithmically-scored tests, enabling clinicians to assess pre-drug/post-drug effects on a composite of heart attack, stroke and cardiac death.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $11.0M
- Funding stage: Seed
- Last round: Non-Equity Assistance (May 2024)
- Website: prevenciomed.com
- Phone: (425) 576-1200
Industries & Categories
Health Care, Health Diagnostics, Medical
Social Profiles
Canonical: https://fsome.com/organization/prevencio-125098 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.